The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Items 201–218 of 218
Psychological and behavioural effects of interferons
Bonaccorso, S., Meltzer, H., & Maes, M. (2000) · Current Opinion in Psychiatry · doi:10.1097/00001504-200011000-00034 · Cited by 40
Abou‐Saleh, M. T., Ghubash, R., Karim, L., Krymski, M., & Anderson, D. N. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00038-8 · Cited by 40
Analysis of IL-1α, IL-1β, and IL-RA Polymorphisms in Dysthymia
Fertuzinhos, S., de Oliveira, J. R. M., Nishimura, A. L., Pontual, D., Carvalho, D. R., Sougey, É. B., Otto, P. A., & Zatz, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:22:3:251 · Cited by 39
Mtabaji, J., Manku, M. S., & Horrobin, D. F. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90161-7 · Cited by 36
Bengtsson, B.-O., Zhu, J., Thorell, L., Olsson, T. P., Link, H., & Wålinder, J. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90180-s · Cited by 36
Fedele, E., & Foster, A. C. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90537-p · Cited by 34
Zhu, J., Bengtsson, B.-O., Mix, E., Thorell, L., Olsson, T. P., & Link, H. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90019-1 · Cited by 32
Differences in interleukins’ patterns between dysthymia and major depression
Schlatter, J., Ortuño, F., & Cervera-Enguix, S. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00585-5 · Cited by 30
Possible association of interleukin-2 treatment with depression and suicide
Baron, D. A., Hardie, T., & Baron, S. (1993) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.1993.93.7.799 · Cited by 30
[26] Indoleamine 2,3-dioxygenase
Yoshida, R., & Hayaishi, O. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(87)42028-4 · Cited by 28
Chen, Z.-J., Vetter, M., Chang, G.-D., Liu, S., & Chang, C.-H. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702685 · Cited by 25
Glial Pathology in Major Psychiatric Disorders
Cotter, D., Pariante, C. M., & Rajkowska, G. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_5 · Cited by 22
5-HT and Depression: the Present Position
Coppen, A., & Swade, C. (1988) · doi:10.1007/978-1-349-09506-3_9 · Cited by 20
The Post‐Mortem Brain in Psychiatric Research
Jellinger, K. A. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00522_1.x · Cited by 20
Exacerbation of schizophrenia associated with amantadine
Nestelbaum, Z., Siris, S. G., Rifkin, A. E., Klar, H., & Reardon, G. T. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.9.1170 · Cited by 19
Can rodents be used to model interferon-α-induced depressive symptoms?
Loftis, J. M., Hauser, P., Macey, T. A., & Lowe, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.004 · Cited by 16
Immunology in Anxiety and Depression
Schwarz, N. (2003) · doi:10.3109/9780203911822-12 · Cited by 16
Role of the cytokine network in major psychoses
Müller, N., & Schwarz, M. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31045-8 · Cited by 12
Self-citation
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“Quinolinic acid also induces oxidative stress, which in combination with glutamate release may contribute to CNS excitotoxicity (see below) (36,40-42).”
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.